Document is current
Any future updates will be listed below
-
Authors
Xia, Shuai
Chan, Jasper Fuk-Woo
Wang, Lijue
Jiao, Fanke
Chik, Kenn Ka-Heng
Chu, Hin https://orcid.org/0000-0003-2855-9837
Lan, Qiaoshuai https://orcid.org/0000-0001-5524-3542
Xu, Wei
Wang, Qian
Wang, Chao
Yuen, Kwok-Yung https://orcid.org/0000-0002-2083-1552
Lu, Lu https://orcid.org/0000-0002-2255-0391
Jiang, Shibo https://orcid.org/0000-0001-8283-7135
- License Information
-
More Information
Article History
Received: 20 December 2021
Accepted: 5 January 2022
First Online: 27 January 2022
Competing interests
: S.J., L.L., S.X., W.X. and Q.W. are the inventors in the patent or patent application covering the peptides EK1, EK1C4 and EKL1C. J.F.-W.C. has received travel grants from Pfizer Corporation Hong Kong and Astellas Pharma Hong Kong Corporation Limited and was an invited speaker for Gilead Sciences Hong Kong Limited and Luminex Corporation. Other authors declare that they have no competing interest.
Free to read: This content has been made available to all.
